(Q50799679)

19 March 2018

title

Newer anticonvulsants: lamotrigine, topiramate and gabapentin (English)

1 reference

19 March 2018

0 references

1 reference

Lewis B Holmes

1

1 reference

19 March 2018

Sonia Hernandez-Diaz

series ordinal

2

1 reference

19 March 2018

publication date

22 June 2012

1 reference

19 March 2018

Birth Defects Research Part A: Clinical and Molecular Teratology

published in

1 reference

19 March 2018

volume

94

1 reference

19 March 2018

issue

8

1 reference

19 March 2018

page(s)

599-606

1 reference

19 March 2018

A Comparison of the Pharmacokinetics and Pharmacodynamics of Pregabalin and Gabapentin

cites work

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23028

Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23028

Lamotrigine and the risk of malformations in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23028

Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23028

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23028

Gabapentin use in hyperemesis gravidarum: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23028

Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): obstetrical complications and change in seizure frequency: report of the Quality Standards Subcommittee and Therapeutics and Technol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23028

Comparative safety of antiepileptic drugs during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23028

Teratogenic effects of antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23028

Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23028

The correlation of deficits in IQ with midface and digit hypoplasia in children exposed in utero to anticonvulsant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23028

The teratogenicity of anticonvulsant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23028

Evaluation of selected characteristics of pregnancy drug registries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23028

Topiramate in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23028

Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23028

Drug interactions involving the new second- and third-generation antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23028

Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23028

Treatment of epilepsy in adults: expert opinion, 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23028

Obstetric outcomes in women with multiple sclerosis and epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23028

Prescription patterns of antiepileptic drugs in patients with epilepsy in a nation-wide population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23028

Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23028

Outcome of pregnancy in women attending an outpatient epilepsy clinic: adverse features associated with higher doses of sodium valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23028

Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23028

Foetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23028

Gabapentin exposure in human pregnancy: results from the Gabapentin Pregnancy Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23028

A clinical study of 57 children with fetal anticonvulsant syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23028

Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23028

Language skills of school-aged children prenatally exposed to antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23028

Plasma concentrations of lamotrigine and its 2-N-glucuronide metabolite during pregnancy in women with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23028

Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23028

The outcome of pregnancy following topiramate treatment: a study on 52 pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23028

Craniofacial skeletal deviations following in utero exposure to the anticonvulsant phenytoin: monotherapy and polytherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23028

Antiepileptic drug pharmacokinetics during pregnancy and lactation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23028

Developmental toxicity studies in mice, rats, and rabbits with the anticonvulsant gabapentin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23028

Pharmacokinetics and therapeutic drug monitoring of newer antiepileptic drugs during pregnancy and the puerperium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23028

Pregnancy registries: differences, similarities, and possible harmonization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23028

Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23028

The Australian Register of Antiepileptic Drugs in Pregnancy: the first 1002 pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23028

Teratogenicity of the newer antiepileptic drugs--the Australian experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23028

Pregnancy, delivery, and outcome for the child in maternal epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23028

Newer-Generation Antiepileptic Drugs and the Risk of Major Birth Defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23028

21 January 2018

Identifiers

DOI

10.1002/BDRA.23028

1 reference

19 March 2018

1 reference

19 March 2018